204 related articles for article (PubMed ID: 38619621)
1. CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survival.
Wedig J; Jasani S; Mukherjee D; Lathrop H; Matreja P; Pfau T; D'Alesio L; Guenther A; Fenn L; Kaiser M; Torok MA; McGue J; Sizemore GM; Noonan AM; Dillhoff ME; Blaser BW; Frankel TL; Culp S; Hart PA; Cruz-Monserrate Z; Mace TA
Cancer Immunol Immunother; 2024 Apr; 73(6):96. PubMed ID: 38619621
[TBL] [Abstract][Full Text] [Related]
2. CD200 promotes immunosuppression in the pancreatic tumor microenvironment.
Choueiry F; Torok M; Shakya R; Agrawal K; Deems A; Benner B; Hinton A; Shaffer J; Blaser BW; Noonan AM; Williams TM; Dillhoff M; Conwell DL; Hart PA; Cruz-Monserrate Z; Bai XF; Carson WE; Mace TA
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581043
[TBL] [Abstract][Full Text] [Related]
3. CD200-CD200R Pathway in the Regulation of Tumor Immune Microenvironment and Immunotherapy.
Liu JQ; Hu A; Zhu J; Yu J; Talebian F; Bai XF
Adv Exp Med Biol; 2020; 1223():155-165. PubMed ID: 32030689
[TBL] [Abstract][Full Text] [Related]
4. CD200 is overexpressed in neuroblastoma and regulates tumor immune microenvironment.
Xin C; Zhu J; Gu S; Yin M; Ma J; Pan C; Tang J; Zhang P; Liu Y; Bai XF; Mo X; Xu M; Zhu H
Cancer Immunol Immunother; 2020 Nov; 69(11):2333-2343. PubMed ID: 32514618
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD200 Correlates With Interleukin-6 Levels in Sera of COPD Patients: Potential Implication of the CD200/CD200R Axis in the Disease Course.
Sakthivel P; Breithaupt A; Gereke M; Copland DA; Schulz C; Gruber AD; Dick AD; Schreiber J; Bruder D
Lung; 2017 Feb; 195(1):59-68. PubMed ID: 27864635
[TBL] [Abstract][Full Text] [Related]
6. CD200/CD200R: Bidirectional Role in Cancer Progression and Immunotherapy.
Nip C; Wang L; Liu C
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137547
[TBL] [Abstract][Full Text] [Related]
7. The CD200-CD200R Axis Promotes Squamous Cell Carcinoma Metastasis via Regulation of Cathepsin K.
Khan IZ; Del Guzzo CA; Shao A; Cho J; Du R; Cohen AO; Owens DM
Cancer Res; 2021 Oct; 81(19):5021-5032. PubMed ID: 34183355
[TBL] [Abstract][Full Text] [Related]
8. CD200 Baseline Serum Levels Predict Prognosis of Chronic Lymphocytic Leukemia.
D'Arena G; Vitale C; Coscia M; Lamorte D; Pietrantuono G; Perutelli F; D'Auria F; Statuto T; Valvano L; Tomasso A; Griggio V; Jones R; Mansueto G; Villani O; D'Agostino S; Viglioglia V; De Feo V; Calapai F; Mannucci C; Sgambato A; Efremov DG; Laurenti L
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439393
[TBL] [Abstract][Full Text] [Related]
9. Different mechanisms of CD200-CD200R induce diverse outcomes in cancer treatment.
Liao KL; Watt KD; Protin T
Math Biosci; 2023 Sep; 365():109072. PubMed ID: 37734537
[TBL] [Abstract][Full Text] [Related]
10. Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes, Cancer-Associated Fibroblasts, and CD200 in Pancreatic Cancer.
MacNeil T; Vathiotis IA; Shafi S; Aung TN; Zugazagoitia J; Gruver AM; Driscoll K; Rimm DL
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771664
[TBL] [Abstract][Full Text] [Related]
11. sCD200 present in mice receiving cardiac and skin allografts causes immunosuppression in vitro and induces Tregs.
Gorczynski R; Chen Z; Khatri I; Yu K
Transplantation; 2013 Feb; 95(3):442-7. PubMed ID: 23380863
[TBL] [Abstract][Full Text] [Related]
12. TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer.
Perez-Penco M; Weis-Banke SE; Schina A; Siersbæk M; Hübbe ML; Jørgensen MA; Lecoq I; Lara de la Torre L; Bendtsen SK; Martinenaite E; Holmström MO; Madsen DH; Donia M; Ødum N; Grøntved L; Andersen MH
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600556
[TBL] [Abstract][Full Text] [Related]
13. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer.
Sadozai H; Acharjee A; Eppenberger-Castori S; Gloor B; Gruber T; Schenk M; Karamitopoulou E
Front Immunol; 2021; 12():643529. PubMed ID: 33679807
[No Abstract] [Full Text] [Related]
14. Cancel cancer: The immunotherapeutic potential of CD200/CD200R blockade.
Choe D; Choi D
Front Oncol; 2023; 13():1088038. PubMed ID: 36756156
[TBL] [Abstract][Full Text] [Related]
15. Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice.
Peran I; Dakshanamurthy S; McCoy MD; Mavropoulos A; Allo B; Sebastian A; Hum NR; Sprague SC; Martin KA; Pishvaian MJ; Vietsch EE; Wellstein A; Atkins MB; Weiner LM; Quong AA; Loots GG; Yoo SS; Assefnia S; Byers SW
Gastroenterology; 2021 Mar; 160(4):1359-1372.e13. PubMed ID: 33307028
[TBL] [Abstract][Full Text] [Related]
16. CD200 Blockade Modulates Tumor Immune Microenvironment but Fails to Show Efficacy in Inhibiting Tumor Growth in a Murine Model of Melanoma.
Talebian F; Yu J; Lynch K; Liu JQ; Carson WE; Bai XF
Front Cell Dev Biol; 2021; 9():739816. PubMed ID: 34692697
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum soluble CD200 and CD200R as surrogate markers of bone loss under bed rest conditions.
Kos O; Hughson RL; Hart DA; Clément G; Frings-Meuthen P; Linnarsson D; Paloski WH; Rittweger J; Wuyts F; Zange J; Gorczynski RM
Bone; 2014 Mar; 60():33-40. PubMed ID: 24333170
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Tumor Microenvironment.
Wang K; He H
Adv Exp Med Biol; 2020; 1296():243-257. PubMed ID: 34185297
[TBL] [Abstract][Full Text] [Related]
19. CD200 and CD200R Expression on Peripheral Blood Lymphocytes and Serum CD200 Concentration as a New Marker of Endometriosis.
Abramiuk M; Grywalska E; Korona-Głowniak I; Niedźwiedzka-Rystwej P; Polak G; Kotarski J; Roliński J
J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32967175
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia.
Memarian A; Nourizadeh M; Masoumi F; Tabrizi M; Emami AH; Alimoghaddam K; Hadjati J; Mirahmadian M; Jeddi-Tehrani M
Tumour Biol; 2013 Feb; 34(1):531-42. PubMed ID: 23179394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
